BOLT BIOTHERAPEUTICS INC. - COMMON STOCK
0.5786
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.0118
+2.08%
Today's range
0.5600 - 0.5830
ISIN
N/A
Source
NASDAQ
-
Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
07 Aug 2023 15:10:00 By Nasdaq GlobeNewswire
-
03 Aug 2023 06:30:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023
31 Jul 2023 16:27:56 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
11 May 2023 15:05:01 By Nasdaq GlobeNewswire
-
26 Apr 2023 09:00:00 By Nasdaq GlobeNewswire
-
29 Mar 2023 15:15:00 By Nasdaq GlobeNewswire
-
29 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
14 Mar 2023 15:30:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare Conference
28 Feb 2023 07:00:05 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at February Investor Conferences
01 Feb 2023 07:00:02 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Appoints Laura Berner to Board of Directors
14 Dec 2022 15:43:15 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
10 Nov 2022 15:05:02 By Nasdaq GlobeNewswire
-
07 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Stifel 2022 Healthcare Conference
01 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
31 Aug 2022 06:30:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
10 Aug 2022 15:05:01 By Nasdaq GlobeNewswire
-
27 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights
12 May 2022 15:05:01 By Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference
07 Apr 2022 07:00:01 By Nasdaq GlobeNewswire